As a diabetes patient, always be prepared for your doctor’s visit with a list of detailed, thoughtful questions that can help ...

Eli Lilly has outpaced Ozempic-maker Novo Nordisk in the race to develop new incretin drugs.The company is set to capture 50% of the $95 billion obesity market by 2050.We got a glimpse into Eli ...